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Reducing Readmission Rates
Does Coronary Artery Bypass Graft Surgery
Provide Clarity?*
John S. Rumsfeld, MD, PHD,†‡§
Larry A. Allen, MD, MHS‡§
Denver and Aurora, Colorado
Because hospital readmissions are costly and potentially
avoidable, reducing hospital readmission rates has been
touted as a means to improve quality and reduce costs.
Cardiovascular disease is a natural focus for this because
of overall costs of treatment and frequency of readmission
(e.g., nearly 1 in 4 Medicare patients is readmitted within
30 days after hospitalization for heart failure) (1). Since
2009, hospital-level 30-day risk-standardized readmis-
sion rates for acute myocardial infarction and heart failure
have been publicly reported for Medicare patients (1).
See page 569
Starting in 2013, those outcomes measures will be linked to
Medicare reimbursement. That has prompted an intense
flurry of interest in reducing hospital readmission rates
across all sectors of the U.S. healthcare system. Yet, hospital
readmission is a complex, multifactorial outcome measure,
and it remains unclear how hospital readmission rates can
effectively and safely be lowered.
In this issue of JACC: Cardiovascular Interventions, Han-
nan et al. (2) provide important clarity about readmission
fter coronary artery bypass graft (CABG) surgery. Studying
actors associated with readmission among30,000 CABG
urgery patients in New York State, the authors made
everal important findings. First, the most common cause of
eadmission within 30 days after CABG surgery was pro-
edural complications. Post-operative infection and other
omplications together accounted for25% of the readmis-
ions. The next most common reason for readmission was
eart failure, accounting for nearly 13%. Second, there was
2.5-fold range of 30-day hospital readmission rates among
ospitals. Finally, consistent with other literature, there was
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ortality rates.
Why are these findings important? On the one hand, they
einforce that a principal focus on patient characteristics as
way of targeting interventions is unlikely to significantly
ower hospital readmission rates. Patient characteristics may
e associated with readmission, but they explain only a small
roportion of the variance in the outcome and tend to be
onmodifiable (e.g., age). Risk models of hospital readmis-
ion have generally been shown to have poor discrimination,
imiting their clinical utility (3).
On the other hand, finding that the most common cause
f readmission is complications, and that there is a wide
ange of readmission rates across hospitals, argues strongly
hat the answer lies in improving institutional quality of
are. Complication rates for CABG surgery are long-
tanding, validated quality measures, and the variability in
eadmission rates between institutions is a strong argument
hat some of these readmissions are preventable (4). At least
ome of the observed variation is a reflection of variation in
uality of care. A number of interventions are known to
educe post-operative infections, arrhythmias, pneumonias,
yocardial infarction, and venous thromboembolism—all
f which were identified as common causes of readmission
n New York State’s post-CABG population.
Interestingly, recent data on cardiac surgery outcomes in
he United Kingdom bolster the implications of the findings
f the study by Hannan et al. (2). It has recently been shown
hat outcomes among cardiac surgery patients in the United
ingdom are better than in other parts of Europe; these
esults have been attributed to a commitment to quality
easurement and improvement (5). Similarly, rehospital-
zation rates after cardiac surgery are significantly lower in
he United Kingdom than in the United States. Although
ength of stay is similar to that in the United States, 75%
f cardiac surgery patients in the United Kingdom receive
ardiac rehabilitation after discharge, far outpacing the
nited States. It is not a stretch to postulate that more
obust post-discharge care helps in earlier identification and
reatment of complications that evolve after discharge,
eading to fewer rehospitalizations.
The United Kingdom story thereby reinforces the mes-
age that a commitment to inpatient quality measures and
mproved transitions of care from the inpatient to the
utpatient setting can translate into improved outcomes.
rior studies have identified gaps in transitions of care, such
s a lack of early follow-up after heart failure hospitalization
r medication errors, as factors associated with unnecessary
eadmission (6). In addition, interventions focused on im-
roving transitions of care, such as transition coaches, have
een shown to reduce readmission rates (7). This body of
nowledge helps justify efforts, such as the American
ollege of Cardiology/Institute for Healthcare Improve-
ent Hospital to Home Quality Initiative, that are focused
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578on care transitions in the effort to reduce unnecessary
rehospitalization among cardiovascular patients. The cur-
rent study (2) supports these efforts, suggesting that a strong
focus on reducing periprocedural complications—in the
hospital and in the transition period after discharge—should
be a point of emphasis for such initiatives.
The frequency of readmission for heart failure after
hospital discharge for CABG surgery in the study by
Hannan et al. (2) also “fits” this picture. The finding may be
somewhat surprising, given that successful revascularization
will have been accomplished in most cases. Some may argue
that heart failure after CABG surgery is another complica-
tion; others may assert it is endemic to chronic heart failure
present in many CABG surgery patients. Either way, heart
failure management in the post-procedure setting should be
a modifiable target for quality improvement, and this again
supports the need for optimal transitions of care from
hospital to home.
Finally, the study by Hannan et al. (2) reinforces the
difference between mortality and rehospitalization mea-
sures. While 30-day mortality rates have fallen in recent
decades, readmission rates have remained steady. Intrahos-
pital correlation between risk-adjusted mortality and read-
mission rates is poor. This lack of correlation between
mortality and readmission rates has been seen among
patients hospitalized for other conditions (8). The belief
that outcomes measures should move in the same direc-
tion—namely, that mortality rates automatically reflect all
domains of quality—is overly simple. Concordance will only
be present if different outcomes measures capture largely
overlapping domains of quality. There are reasons that the
quality domains of 30-day mortality and readmission are
distinct. For example, surgical experience with graft implan-
tation and pre-operative selection/anesthesia are likely to
largely improve survival; in contrast, transitions-of-care
interventions and antiseptic sternal care are more likely to
decrease readmissions. Therefore, a variety of outcomes
measures are likely to be needed for each therapy to capture
the range of relevant performance domains and improve the
overall value of care as it matters to patients.
The real challenge is translating all of this into clinical
practice. The current U.S. healthcare system still incentiv-
izes readmission. In fact, diagnosis-related group payments
have been linked to shorter length of stay with increases in
readmission rates (8). The effectiveness, costs, implementa-
ion, and “ownership” of interventions that focus on the
ransition period between inpatient and outpatient care all
emain to be adequately addressed. Nonetheless, healthcarereform promises to emphasize “episodes of care” that bridge
inpatient and outpatient care. Starting in 2011, Medicare’s
value-based purchasing will provide differential reimburse-
ment based on quality measures. Although the initial quality
measures will be processes of care, outcomes measures
including rehospitalization for cardiac conditions and pro-
cedures are set to follow in short order.
In an environment in which consumer groups, clinicians,
hospitals, health systems, and payers are highly cognizant
that readmission rates are being emphasized as measures of
quality and will be tied to reimbursement, the study by
Hannan et al. (2) provides a simple but powerful message:
we must work for evidence-based reductions in unnecessary
rehospitalization. As such, efforts to reduce procedural
complication rates and improve transitions of care should be
centric to quality improvement. If that happens, it may not
only help the financial bottom line of hospitals and the
country, but more important, it can help individual patients
and their families.
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